Source: Υπουργείο Υγείας (CY) Revision Year: 2020 Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
Dividol 10 mg coated tablets.
| Pharmaceutical Form |
|---|
|
Coated tablet. White, round, sugar-coated tablets. |
Each coated tablet contains 10 mg hyoscine butylbromide.
Excipient(s) with known effect: This product contains 32.5 mg lactose and 47.718 mg sucrose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Butylscopolamine |
Butylscopolamine is an antispasmodic agent which relaxes smooth muscle of the organs of the abdominal and pelvic cavities. It is believed to act predominantly on the intramural parasympathetic ganglia of these organs. |
| List of Excipients |
|---|
|
Core: Cellulose, microcrystalline Coating: Gelatin |
PVC/Aluminium blisters. Pack sizes of 20 and 100 coated tablets.
PP containers with PE closure. Pack size of 1000 coated tablets.
Not all pack sizes may be marketed.
Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
19675
Date of first authorization: 07 June 2005
Date of latest renewal: 11 April 2011
| Drug | Countries | |
|---|---|---|
| DIVIDOL | Albania, Cyprus, Hong Kong, Malta |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
